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The Peroxisome proliferator-activated receptor-
gamma coactivator 1 alpha (PGC-1a) is a transcrip-
tional co-activator that plays a central role in adapted
metabolic responses. PGC-1a is dynamicallymethyl-
ated and unmethylated at the residue K779 by the
methyltransferase SET7/9 and the Lysine Specific
Demethylase 1A (LSD1), respectively. Interactions
of methylated PGC-1a[K779me] with the Spt-Ada-
Gcn5-acetyltransferase (SAGA) complex, the Medi-
ator members MED1 and MED17, and the NOP2/
Sun RNAmethytransferase 7 (NSUN7) reinforce tran-
scription, and are concomitant with the m5Cmark on
enhancer RNAs (eRNAs). Consistently, loss of Set7/9
and NSun7 in liver cell model systems resulted
in depletion of the PGC-1a target genes Pfkl, Sirt5,
Idh3b, and Hmox2, which was accompanied by
a decrease in the eRNAs levels associated with
these loci. Enrichment of m5C within eRNA species
coincides with metabolic stress of fasting in vivo.
Collectively, these findings illustrate the complex
epigenetic circuitry imposed by PGC-1a at the
eRNA level to fine-tune energy metabolism.
INTRODUCTION
Processes that contribute to a rapid transcriptional response
when the biological need for energy arises converge on the
Peroxisome proliferator-activated receptor-gamma coactiva-
tor 1 alpha (PGC-1a) (Finck and Kelly, 2006; Knutti and Kralli,
2001; Lin et al., 2005; Lowell and Spiegelman, 2000; Rosenfeld
et al., 2006; Scarpulla, 2008). PGC-1a is a transcriptional co-Cactivator that interacts with selective transcription factors and
chromatin-remodeling complexes to modulate the transcription
of target genes (Aubert et al., 2009). Because PGC-1a has a
highly conserved and functional RNA recognition motif (RRM)
(Monsalve et al., 2000), interactions with enhancer-associated
RNAs (eRNAs), tethering critical proteins to chromatin, could
regulate an adaptive metabolic response in an alternative
manner (Natoli and Andrau, 2012; Shiekhattar, 2013).
Biological models illustrating the role of epigenetic and post-
translational modifications of co-activators and co-repressor
as functional signatures for transcriptional activity have emerged
(Berger, 2002, 2007; Jenuwein and Allis, 2001; Rosenfeld et al.,
2006). PGC-1a is acetylated by the histone acetyltransferase
GCN5 of the Spt-Ada-Gcn5-acetyltransferase (SAGA) complex
(Kelly et al., 2009; Lerin et al., 2006), deacetylated by SIRT1
(Nemoto et al., 2005; Rodgers et al., 2005), serine phosphory-
lated by AKT/PKB (Li et al., 2007), AMPK, p38 MAPK, and
GSK3b (Fernandez-Marcos and Auwerx, 2011), and asymmet-
rically dimethylated by PRMT1 (Teyssier et al., 2005). These
post-translational modifications can occur in an exclusive or
combined manner, and may reinforce or diminish the potential
of PGC-1a to co-activate transcription under diverse metabolic
conditions (Canto´ and Auwerx, 2009), resulting in defective con-
trol of multiple transcriptional networks (Lerin et al., 2006; Li
et al., 2007; Teyssier et al., 2005). On the other hand, lysine
methylation by the histone mono-methyltransferase SET7/9,
and lysine demethylation by the Lysine Specific Demethylase 1
(LSD1), have been shown to play an important role in non-his-
tone proteins such as p53 and DNMT1 (Chuikov et al., 2004;
Este`ve et al., 2009; Nicholson and Chen, 2009; Pradhan et al.,
2009; Wang et al., 2009).
Chemical modification also occurs on RNA, functioning as a
sensor of the metabolic status to influence gene regulatory net-
works at the epigenetic level (Towns and Begley, 2012). The
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Figure 1. PGC-1a Is a Direct Substrate for LSD1 and SET7/9 and theMethylation State Is Associated with Enhanced Transcription Activation
(A) LSD1 and PGC-1a western blot of nuclear extracts from Hepa 1-6 infected with control or Lsd1 shRNA (upper). These nuclear extracts were used for SILAC
assays (below). The mass spectra revealed PGC-1a as a significant substrate for LSD1.
(B) Autoradiography for in vitro methylation assays performed with the recombinant C-terminal domain of the human PGC-1a protein and the recombinant
methyltransferases indicated in the figure. For the demethylation assay, recombinant C-terminal domain of the human PGC-1a was incubated with a constant
amount of SET7/9 and increased amounts of LSD1. Coomassie staining was used as a loading control (lower).
(C) Steady-state kinetic analysis of wild-type PGC-1a[K779] and mutant PGC-1a[K779R] peptides for in vitro reactions with recombinant SET7/9 enzyme.
(D) Direct interaction studies of [His]6-tagged C-terminal domain (C-term), RNA recognition motif (RRM), or amino acids 697 to 798 (697–798) of human PGC-1a
(as shown in scheme) with GST-tagged human SET7/9 (left) or GST-tagged SWIRM domain of human LSD1 (right).
(legend continued on next page)
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RNA methyltransferases NSUN2 (Misu), NSUN3, NSUN4,
NSUN5 (Wbscr20, Wbscr20a), NSUN6 (NOPD1), and NSUN7
that catalyze the methylation of cytosine to 5-methylcytosine
(m5C). This modification appears to be ubiquitous (Squires
et al., 2012), yet its significance is poorly understood. NSUN5
and NSUN7 have been linked to organism lifespan in yeast
(Schosserer et al., 2015) and male sterility, respectively (Harris
et al., 2007; Khosronezhad et al., 2014). Moreover, NSun7 is
highly expressed during murine embryogenesis where energy
needs are considered high (Chi and Delgado-Olguı´n, 2013). At
the molecular level, m5C methylation by NSUN2 in tRNAs and
within the 30UTR of the INK4AmRNA promotes stability by abro-
gating RNA cleavage (Khoddami and Cairns, 2013; Tuorto et al.,
2012; Zhang et al., 2012) and in non-coding RNA (ncRNAs) con-
trols the processing of vault ncRNAs into small regulatory RNAs
(srRNAs) (Hussain et al., 2013). Conversely, combined loss of
NSun2 and Dnmt2 in mouse genetic models leads to early
embryonic lethality through disruption of the protein synthesis
pathway because tRNAs are lost (Tuorto et al., 2012).
Here, we demonstrate that PGC-1a is a substrate for both
LSD1 and SET7/9. Lysine methylation of PGC-1a is directed at
the residue K779 and appears selectively coupled to eRNAs
with increased retention of the Spt-Ada-Gcn5-acetyltransferase
(SAGA) complex component CCDC101/SGF29, and Mediator 1
and 17. Loss of Set7/9 diminished the capacity to retain the
SAGA/ Mediator complex, and consequentially diminished the
capacity of PGC-1a to stimulate transcription. Selective ablation
of these eRNAs in mouse hepatoma cells and primary hepato-
cytes corresponded with diminished expression of their asso-
ciated genes. Therefore, interactions between PGC-1a and
NSUN7 appear to account for the enrichment of m5C-modified
eRNAs at enhancers of specific target genes, which fine-tunes
RNA polymerase II activity to metabolic cues. Moreover, enrich-
ment of m5C within these specific eRNA species coincides with
metabolic stress of fasting in liver in vivo. We therefore link inter-
genic and eRNAs with post-translationally modified PGC-1a and
the transcriptional program of an adaptive metabolic response.
RESULTS
Identification of LSD1 Substrates
Several protein lysine methyltransferases and demethylases
have been identified to have critical roles in non-histone proteins,
affecting human pathogenesis (Hamamoto et al., 2015). To iden-
tify specific substrates of LSD1 in Hepa 1-6 cells we used short
hairpin RNAs (shRNAs) targeting the expression of murine Lsd1
(Figure 1A) following stable isotope labeling by amino acids
in cell culture (SILAC) assay. PGC-1a was identified among
twenty-seven candidate gene products with a spectra profile(E) MS of the in vitro methylation assay of PGC-1a[K779] synthetic peptide with
(F) HEK293 cells were transfected with triple FLAG-tagged human PGC-1a and c
dialdehyde (AdOx), cycloheximide (CHX), and chloramphenicol (CA). Inhibition
metabolic labeling, 3XFLAG/hPGC-1a was immunoprecipitated with anti-FLAG M
(G) Schematic diagram illustrating the luciferase-coding gene under the control
construct was transfected with the expression vector encoding wild-type PGC-1a
fused to the Gal4 DNA binding domain (left). Luciferase activity wasmeasured 48 h
from transfected cultures using primers overlapping the GAL4 UAS (right).
Cthat had a strong preference for monomethylated and dimethy-
lated lysine 779 (K779me1 > K779me2 > K779me0) (Figure 1A).
To determine if K779 methylation was a specific post-transla-
tional modification of PGC-1a, we directed lysine and arginine
methyltransferase activities toward the recombinant C terminus
of human PGC-1a in vitro, containing the K779 residue. Results
revealed that K779 of PGC-1a was preferentially methylated by
PRMT1 and SET7/9, whereas G9a, SUV39H1, or PRMT4 failed
to methylate this substrate (Figure 1B). Furthermore, we sought
to determine if LSD1 could reverse the abundance of [14C]-meth-
ylated PGC-1a species on a stoichiometric basis. Hence,
we titrated up to 3-fold molar equivalent of recombinant LSD1
with SET7/9 and PGC-1a (Figure 1B) and demonstrated the
competing activities between SET7/9 and LSD1 on the C termi-
nus of PGC-1a. To determine the efficiency of SET7/9-mediated
PGC-1a[K779] methylation, a constant amount of SET7/9 and 3H
[AdoMet] was incubated with increasing amounts of either wild-
type (PGC-1a[K779]) or mutant synthetic peptides in which K779
was replaced by an arginine (PGC-1a[K779R]). We found that the
reaction rate curve for the wild-type PGC-1a[K779] was higher
than for the mutant PGC-1a[K779R] peptide (Figure 1C), sug-
gesting that the lysine K779 of PGC-1a is an efficient and specific
substrate for SET7/9. The model structure of the PGC-1a[K779]
peptide accommodated in the catalytic pocket of SET7/9
enzyme is shown in Figure S1A.
Direct Interactions with PGC-1a Are Shared between
SET7/9 and the SWIRM Domain of LSD1
To further study the nature of PGC-1a interaction with LSD1 and
SET7/9, we performed binding assays with recombinant pro-
teins corresponding to various C-terminal fragments of PGC-
1a fused to the polyhistidine tag of pET28b, and GST-tagged
SET7/9 or the SWIRM domain of LSD1. PGC-1a directly bound
to SET7/9 and the SWIRM domain of LSD1 in vitro (Figure 1D)
and in vivo, as this interaction was also detected in a native
cellular context (Figure S1B). To determine the nature of lysine
methylation of PGC-1a, we conducted direct in vitro methyl-
ation reactions with either wild-type or mutant SET7/9 enzyme,
and the synthetic peptide PGC-1a[K779]. Essentially, MS anal-
ysis revealed enrichment of a single methylated species after
30 min of incubation with the wild-type SET7/9 but not with
the mutated recombinant enzyme (Figure 1E). Confirmation of
SET7/9 activity was also tested on total native histones (Fig-
ure S1C). To examine whether PGC-1a became methylated
in vivo, HEK293 cells were transfected with 3XFLAG tagged
PGC-1a and incubated with L-[methyl-3H]methionine as a
traceable methyl donor. The experiment was performed in the
presence or absence of the homocysteine hydrolase inhibitor
adenosine dialdehyde (AdOx) that blocks generation of thethe wild-type or the catalytically inactive SET7/9 enzyme.
ultured with L-[methyl-3H]methionine, in the presence or absence of adenosine
of translation was monitored by labeling cells with [35S] methionine. After
2 beads and depicted with fluorography.
of Gal4 upstream activating sequences (UAS, pG5luc). The pG5luc reporter
, the C-terminal deletion of PGC-1a (DC-term) or the mutant PGC-1a (K779R),
r after transfection. ChIP for pan-acetyl H3 andGAL4was performed in parallel
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Figure 2. Identification of the Nuclear Methylated PGC-1a[K779me1] Complex
(A) Biotinylated PGC-1a[K779] and PGC-1a[K779me1] synthetic peptides were immobilized on avidin beads and incubated with nuclear extracts of Hepa1-6
cells labeled with [35S] methionine. Parallel PAGE was performed and depicted with fluorography or gel bands excised for peptide identification by MS/MS
analysis.
(B) Peptide pull-down of PGC-1a[K779] or methylated PGC-1a[K779me] peptides with nuclear extracts from Hepa1-6 cells. Immunoblot with specific antibodies
are shown. Avidin beads were used as control.
(C) Peptide pull-down of PGC-1a[K779], PGC-1a[K779me1], PGC-1a[K779me2], H3K4me0, or H3K4me2 with the GST-tagged tandem tudor domain of
the SAGA complex component CCDC101/SGF29 (residues 143–293). Immunoblot with GST antibody (upper) and Coomassie blue staining of the input used
(lower).
(D) Coomassie blue staining of proteins eluted by anti-PGC-1a[K779me] immunoaffinity columns. The lanes were sectioned, digested with trypsin, and the
extracted peptides were sequenced by mass spectrometry. The positions of molecular mass markers are indicated on the left. Naive rabbit IgG was used as a
control shown in the center lane.
(legend continued on next page)
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cellular methyl donor S-adenosyl-methionine (Pless et al., 2008)
and in the presence of cycloheximide and chloramphenicol to
block protein synthesis. Metabolic labeling with 35S-methionine
was used as a control for the inhibition of protein translation in
the presence of cycloheximide and chloramphenicol (Figure 1F,
right). Immunoprecipitation of PGC-1a revealed a 3H-methyl
labeled PGC-1a product in the absence but not in the presence
of AdOx (Figure 1F, left andmiddle). To assess the transcriptional
activity of PGC-1a, we used a heterologous promoter fused with
the Gal4 DNA-binding domain. Loss of the C-terminal domain of
PGC-1a as well as mutant PGC-1a[K779R] led to a decrease in
the luciferase activity (Figure 1G, left), which was accompanied
with a decrease in the abundance of histone H3 acetylation at
the upstream activating sequences (UAS) of the GAL4 promoter
(Figure 1G, right).
Enrichment and Characterization of the PGC-1a
[K779me] Complex
To purify the K779 methyl-specific PGC-1a complex, we used a
combination of affinity and immunoaffinity chromatography.
Hepa 1-6 cells were incubated with [35S]-methionine and the
nuclear extracts were immunoprecipitated with two discrete bio-
tinylated synthetic peptides corresponding to the unmodified
C-terminal of human PGC-1a (PGC-1a[K779]) and a peptide
bearing a specific monomethylated K779 (PGC-1a[K779me1]).
The eluted proteins were electrophoretically separated, de-
picted with fluorography, and the excised bands were subjected
to tandem mass spectrometry (MS/MS) analysis. Methylated
PGC-1a[K779me1] peptide specifically bound to components
of the SAGA complex (CCDC101/SGF29, ADA2, ADA3) and
Mediator (MED1 andMED17) (Figure 2A). The selectivity of these
interactions was tested by peptide pull-down experiments
(Figure 2B). Prominent among the proteins identified was
CCDC101/SGF29, which was previously described as a tandem
Tudor domain containing protein selective for H3K4me2/3 bind-
ing in human and S. cerevisiae (Bian et al., 2011). We then tested
the binding of the recombinant Tudor domain of CCDC101/
SGF29 with different peptides corresponding to methylated
and unmodified species of the C-terminal of PGC-1a and found
a selective binding for PGC-1a[K779me1] and PGC-1a
[K779me2]. H3K4me2was used as a positive control (Figure 2C).
Peptide pull-down experiments showed that the Mediator
component MED17 selectively bound the methylated PGC-1a
[K779me1] but not the PGC-1a[K779] peptide in Hepa 1-6 and
3T3L1 cell lines (Figure S2A).
To assess the robustness of these interactions, Hepa 1-6
extracts were subjected to two purification steps on Phospho-
cellulose P11 and Q Sepharose columns, followed by size
fractionation on a preparative Superose 6 column for a initial
enrichment of >200-fold for the complex. This enriched prep-
aration was divided and applied to immunoaffinity column
composed of a rabbit polyclonal antibody directed against the(E) Immunoprecipitation with anti-PGC-1a[K779me] or with naive IgG serum was
the indicated interacting partners. Immunoblot of PGC-1a[K779me] of the 10% o
(F) UV crosslinked RNA was immunoprecipitated with methylated PGC-1a[K779
using either oligo-dT (o-dT) or random hexamers primers (hex) and labeled with
shown below.
Cmethylated PGC-1a[K779me] peptide (Figures S2B–S2E). The
eluted proteins were identified using MS analysis and listed
alongside the high sensitivity Coomassie blue-stained polyacryl-
amide gel (Figure 2D). Although the hepatoma Hepa 1-6 cell line
with oncogenic properties may provide a distinct composition
from the normal hepatocyte, results from published studies illus-
trated a pool of shared components (Chen et al., 2009; Wallberg
et al., 2003). However, several other candidates remained
uncharacterized as for example, components of the SAGA com-
plex, as well as some orphaned nuclear pore and RNA process-
ing components as the N5cytosine RNA methyltransferase
NSUN7 (Figure 2D). Surprisingly, several Mediator components
were absent, suggesting that alternative compositions may exist
within a native PGC-1a complex. To assert the authenticity of the
interactions we paneled several protein interactions by co-
immunoprecipitation experiments (Figure 2E). We further tested
the possibility of differential RNA binding by methylated and
unmethylated PGC-1a by RNA immunoprecipitation (RIP). The
PGC-1a[K779me] fraction strongly retained RNAs, which were
suspected to be short ncRNAs as they failed to generate any
significant signal from oligo dT mediated reverse transcription
of polyadenylated RNA species (Figure 2F).
Genomic Distribution of PGC-1a[K779me]
To ascertain the distribution of chromatin-bound PGC-1a and
methylated PGC-1a[K779me] we performed chromatin immuno-
precipitation coupled with massively parallel DNA sequencing
(ChIP-seq). Because of the suspected avidity of our custom
antibody (Figures S2B–S2E), the read depth was substantially
greater for the PGC-1a[K779me] than for total PGC-1a,
rendering 9,472 and 2,395 called peaks, respectively, that
were associated with a significant overlapped number of genes
(Figure 3A). The distribution of peaks for PGC-1a[K779me] was
slightly shifted 50 upstream of the TSS when compared with total
PGC-1a (Figure 3B), suggesting an accumulation of intergenic
peaks nearest the adjacent genetic loci. Overall, the density
of PGC-1a[K779me] enrichment still greatly appeared over
the TSS, whereas significant enrichment for both species of
PGC-1awas found at intergenic sites of neighboring genes (Fig-
ure 3C). The genomic distribution of peaks shared between the
PGC-1a[K779me] and total PGC-1a was in concordance with
previous published studies done in human HepG2 cells (Charos
et al., 2012). Most of the overlapped binding sites resided on the
promoters and the intergenic region, although a minority of
peaks was also localized to the intragenic and 30 UTR regions
(Figure 3D). PGC-1a target genes associated with gene ontology
(GO) categories such as positive regulation of transcription,
chromatin modification, and PI3/AKT/mTOR signaling, among
others (Figure 3E). Furthermore, DNA motifs overrepresented
in PGC-1a[K779me] fell into four dominant motif consensus
classes, including the TFIID, LXR, NRF2, and the PPAR family
of transcription factors (Figure 3F, left and middle), which wereperformed from Hep1-6 hepatoma cell nuclear extracts and immunoblotted for
f input used in this assay (lower).
me] and total PGC-1a antibodies. The enriched RNA was reverse -transcribed
CTP, [a-32P]. Input level of methylated PGC-1a[K779me] and total PGC-1a is
ell Reports 14, 479–492, January 26, 2016 ª2016 The Authors 483
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Figure 3. PGC-1a[K779me] Is Associated with
Enhancers and Core Promoters of Metabolic
Genes
(A) Venn diagram representing the overlap of PGC-1a
[K779me] and total PGC-1a bound genes.
(B) Peak distribution of enriched ChIP reads along the
annotated transcriptional start sites (TSS) for PGC-1a
[K779me] and the total pool of PGC-1a.
(C) Density alignment of ChIP peaks relative to
the TSS for PGC-1a[K779me] and unmethylated
PGC-1a.
(D) Genome distribution of the overlapped peaks.
(E) Gene ontology analysis of the PGC-1a[K779me]
ChIP peaks.
(F) Motif discovery from summit regions from PGC-1a
[K779me] ChIP-seq. MEME analysis significantly
identified specific transcription factor (TF) motifs (left)
with their corresponding p values (top right of motif);
TRANSFAC analysis indicates the proportion of TF
motifs found among the overall peak distribution
(center). Custom IGV tracks of genes represented as
sequences enriched for specific TFs derived from the
MEME enrichment analysis (right).localized in four metabolic genes identified as specific targets of
Pgc-1a by knockdown experiments (Figure 3F, right; Fig-
ure S3A): 6-phosphofructokinase (Pfkl), Sirtuin 5 (Sirt5), isocitrate
dehydrogenase 3 (Idh3b), and Heme oxygenase (decycling)
2 (Hmox2). Thus, depletion of Pgc-1a led to a decrease of Pfkl,
Sirt5, Idh3b, and Hmox2 expression, which was rescued with
wild-type PGC-1a, but not mutated PGC-1a[K779R], overex-
pression. The known PGC-1a targets Pepck and Mcad were
tested as controls (Figure S3A). The enrichment of PGC-1a484 Cell Reports 14, 479–492, January 26, 2016 ª2016 The Authors[K779me] at these loci was validated
by chromatin immunoprecipitation (ChIP)-
qPCR in control and Set7/9 knockdown
Hepa 1-6 and differentiated C2C12 cells
(Figure S3B).
PGC-1a[K779me] Potentiates Both
the Expression of Target Genes and
the Corresponding eRNAs Associated
to These Loci
To characterize a functional consequence
for the methylated species of PGC-1a, we
reprogrammed wild-type and Set7/9 /
mouse embryonic fibroblasts (MEFs) to
induced hepatocytes (iHeps), using a modi-
fied described protocol (Sekiya and Suzuki,
2011) (Figure 4A). For a greater efficiency
of hepatocyte transformation, the retroviral
expression of Hnf4a, Foxa1, and Foxa2
was required, as opposed to using a combi-
nation of two factors. Note that the reprog-
ramming efficiency of iHeps was not
affected upon Set7/9 loss (Figure S4A).
PGC-1a expression was induced in iHeps
even in the absence of Set7/9, whereas
methylated PGC-1a[K779me] was depletedin the absence of Set7/9 when compared to the total pool of
PGC-1a (Figures 4B and 4C). Moreover, markers of definitive
hepatocyte differentiation, such as Ntcp and Bsep, and the
nuclear receptor Rxra became more evident (Figures S4B and
S4C) confirming the status of hepatocyte differentiation.
Because PGC-1a[K779me] binding was detected at the active
enhancers of the PGC-1a target genes, characterized by an
enrichment of H3K27ac and components of the SAGA andMedi-
ator complexes (Creyghton et al., 2010; Kagey et al., 2010), and
was found to show stronger retention of ncRNAs, we tested
whether we could detect eRNAs associated with these loci.
Thus, specific primers for each PGC-1a[K779me] enriched
peak upstream of the associated TSS were designed and used
for measuring the transcript abundance. We detected the
expression of eRNAs associated to Pfkl, Sirt5, Idh3b, and
Hmox2 genes, which was drastically abolished upon Set7/9
loss (Figure 4D, right). The changes in eRNA expression levels
strongly correlated with changes in mRNA expression of the
nearby genes (Li et al., 2013) (Figure 4D, left), although the effect
wasmoremoderate. Furthermore, knockdown of Set7/9 in Hepa
and differenciated C2C12 cells was accompanied with a
decrease in the binding of PGC-1a[K779me], MED1, MED17,
and CCDC101/SGF29 at the enhancer of these loci (Figure S3B),
suggesting that methylated PGC-1a[K779me] was essential
for the recruitment of Mediator and SAGA complexes at the
enhancers of the target genes. Next, we infected cells with
wild-type and mutant forms of PGC-1a and showed that only
wild-type PGC-1a corresponded with both modest restitution
of eRNAs as well as mRNA transcripts corresponding with Pfkl
and Sirt5 (Figure S4D), whereas the expression of Foxm1b, a
marker of hepatocyte identity, was independent of the methyl-
ation status of PGC-1a (Figure S4E).
Pfkl-Associated eRNA Is Preferentially Bound by
Methylated PGC-1a
We next examined the RNA binding potential of PGC-1a
[K779me] with the Pfkl-associated eRNA by RIP-Northernblot
(Figure 5A). In both Hepa1-6 and C2C12 cell lines a signal be-
tween 0.5-1 kb was abrogated after knockdown of Set7/9 (Fig-
ure 5B). This result was confirmed by qPCR using the previously
reported Dlx-6as enhancer-associated transcript (Evf-2) as a
negative control for PGC-1a transcript selectivity (Figure 5C)
(Berghoff et al., 2013; Feng et al., 2006). Furthermore, we sought
to text the binding of the Pfkl eRNA with PGC-1a, PGC-1a
[K779me], CCDC101/SGF29, and MED1, and the RNA binding
proteins HEXIM and LARP7. Thus, nuclear extracts from NIH
3T3 and Hepa1-6 cells were incubated with the RNA probe,
and the detected bands were supershifted when PGC-1a,
PGC-1a[K779me], CCDC101/Sgf29 and MED1 specific anti-
bodies were added. No binding of Pfkl-associated eRNA with
either HEXIM or LARP7 was detected, demonstrating selectivity
for the engineered ncRNA transcript by PGC-1a and interacting
protein subunits (Figure 5D).
NSUN7 Promotes PGC-1a-Mediated Transcription and
Corresponds with Enrichment of Specific Enhancer-
Associated Transcripts for Pfkl, Sirt5, Idh3b, andHmox2
To gain deeper mechanistic inside of the association between
NSUN7 and PGC-1a[K779me] (Figure 2D), we performed immu-
noprecipitation assays with specific antibodies against total and
methylated PGC-1a. Western blot of NSUN7 showed that both
PGC-1a and PGC-1a[K779me] species associated with the
NSUN7 (Figure S5A), which was corresponded with a strong
nuclear co-localization as demonstrated by immunocytochem-
istry microscopy (Figure S5B). The staining of NSUN7 was not
confined at the nucleolus but at the nuclear periphery, suggest-
ing that the subcellular localization maybe linked to the cell cycleCand cellular stress (Frye and Watt, 2006). Furthermore, ChIP ex-
periments showed an overlapped binding between methylated
PGC-1a[K779me] and NSUN7 at enhancers of PGC-1a target
genes (Figures 6A and S5C). Depletion of NSun7 corresponded
with moderately diminished expression of Pfkl, Sirt5, Idh3b and
Hmox2 mRNA, but more abrupt decrease of the associated
eRNAs (Figures 6B, S5D, and S5E), suggesting that m5C RNA
mark affects eRNA stability. Additionally, 5-azacytidine-medi-
ated RNA immunoprecipitation (Aza-IP) experiments showed a
decrease of m5C abundance upon NSun7 depletion at the Pfkl,
Sirt5, Idh3b, and Hmox2 eRNAs, indicating that NSUN7 is the
primary methyltransferase for these RNA species (Figures 6C
andS5F). RIP assayswith NSUN7 antibody andm5CRNAdetec-
tion followed by qPCR further confirmed that both stability
and presence of the m5C mark were contingent on NSun7
expression, whereas, Evf-2 transcripts were modestly affected
(Figure S5G). Moreover, analysis of m5C in the Pfkl and Sirt5
eRNAs by Methylamp RNA Bisulfite Conversion Kit in Hepa1-6
cells depleted of NSun7 and/or Pgc1a reinforced the hy-
pothesis that eRNAs selectively undergo cytosine modification
(Figure 6D).
In Vivo Function of eRNAs and Significance of m5C RNA
Modification
To assess whether the studied eRNAs affected transcription
either in cis or in trans, we performed loss-of-function assays
by knockdown of Pfkl and Sirt5-associated eRNAs. Depletion
of Pfkl and Sirt5-eRNAs was accompanied by a decrease in
Pfkl and Sirt5mRNA levels and protein abundance, respectively
(Figures 7A–7C and S6A–S6C), suggesting that these eRNAs
affected transcription of neighboring genes, therefore they
were functioning in cis. Next, we asked whether the Sirt5
eRNA had the capacity to direct a reporter gene by engineering
a trans-activation model similar to what was described (Ørom
et al., 2010). Doxycycline-induced transcription of the Sirt5
eRNA increased Sirt5 reporter activity greater than 4-fold over
the control, indicating that Sirt5 eRNA had enhancer activities
toward Sirt5 expression (Figure 7D). To further evaluate the
physiological function of Sirt5 eRNA, we tested the lysine de-
glutarylase activity of SIRT5 upon knockdown of its associated
eRNA (Tan et al., 2014). We found that carbamoyl phosphate
synthase 1 (CPS1), a specific substrate of SIRT5, was glutary-
lated upon depletion of Sirt5 eRNA, leading to an overall
diminishment in CPS1 activity (Figures 7E and 7F). Overall, these
results suggest that eRNAs are important sensors of the meta-
bolic state.
To further assess the global role of m5C RNA, we measured
NSun7 and Sirt1 expression from liver of fasted DBA/2 mice. Re-
sults indicated that NSun7 was elevated upon 18 hr of fasting
and corresponded with a global increase of m5C RNA (Fig-
ure 7G), detected by quantification of the total cytosine pool in
RNA not converted by bisulfite treatment. We conclude from
these findings that m5C enrichment could be a response to
changes in all RNA species, inclusive of tRNAs and rRNAs (Fig-
ure S6D), reflecting the stability of these RNA species during
metabolic stress. Overall, our work uncovers an unexpected
function of ncRNAs for PGC-1a-mediated transcription, shaped
by pathways that integrate post-translational modification ofell Reports 14, 479–492, January 26, 2016 ª2016 The Authors 485
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Figure 5. Binding to eRNAs Corresponds with the SET7/9-Mediated Methylated State of PGC-1a
(A) Schematic diagram of the murine Pfkl locus. The position of the eRNA probe used in different assays is shown.
(B) Binding of PGC-1a[K779me] to Pfkl-associated eRNA was analyzed by RIP Northern blot analysis upon knockdown of Set7/9 in both Hepa 1-6 and C2C12
cells. Detection of Gapdh mRNA was used as a control (lower).
(C) qPCR of the Pfkl-associated eRNA and the Dlx2 enhancer-associated Evf-2 (Dlx6os1) transcript used as a negative control, after RIP with PGC-1a[K779me]
antibody upon Set7/9 depletion in both Hepa 1-6 and C2C12 cells. Shown are the relative abundance for 10% of total input of PGC-1a as a total and methylated
K779 fractions.
(D) RNA EMSA using Hepa 1-6 nuclear extracts and the radiolabeled RNA probe corresponding to the Pfkl-associated eRNA described in (A). The indicated
antibodies were added to detect supershifted bands.PGC-1a with eRNAs and NSUN7. We suggest these studies will
contribute to an emerging understanding of how dynamically
modified eRNAs may influence transcriptional responses to
adaptive metabolic stress (Figure 7H).
DISCUSSION
The post-translational modifications of PGC-1a and their
influence on its transcriptional activity have been well studied
(Fernandez-Marcos and Auwerx, 2011), and they are relatedFigure 4. Loss of Set7/9 Contributes to eRNAs Depletion
(A) Schematic diagram illustrating the transdifferentiation protocol of wild-type a
(B) Immunocytochemistry analysis of wild-type and Set7/9 null iHep, using PGC
(right). DAPI was used for DNA staining (left).
(C) Western blot of total PGC-1a and PGC-1a[K779me] in wild-type and Set7/9
(D) qPCR assays of thePfkl,Sirt5, Idh3b, andHmox2mRNA transcripts (left) and th
and MEFs.
Cwith the rapid ability to change protein activity and function
in response to metabolic stimuli. In this report, we showed
that PGC-1a undergoes lysine methylation and demethy-
lation at K779 mediated by SET7/9 and LSD1, respectively.
Understanding the mechanism and the consequences of
PGC-1a methylation may lead to a mean to modulate
PGC-1a activity and intervene in metabolic diseases. The
methylated pool of PGC-1a corresponds with the retention
of SAGA and Mediator complexes, a number of RNA binding
proteins, and with the aggregation of ncRNAs, postulatingnd Set7/9 null (Set7/9 /) MEFs into induced hepatocytes (iHeps).
-1a[K779me] and PGC-1a antibodies and rhodamine-labeled anti-rabbit IgG
/ iHep and MEFs, respectively. GAPDH was used as a loading control.
e associated eRNAs upstream the TSS (right) in wild-type and Set7/9/ iHep
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whether this feature of PGC-1a activity is linked to its control
of transcription.
To reveal specific methylated and unmethylated PGC-1a
target genes, we conducted ChIP-seq studies in Hepa1-6 cells.
Our analysis revealed some discrepancies in the number of
peaks for PGC-1a and PGC-1a[K779me], likely indicating the
poor avidity of the commercial antibody used in our ChIP exper-
iments. In contrast, the custom antibody raised against methyl-
ated PGC-1a[K779me] was optimized for ChIP studies and
seemed to reflect the depth of coverage of the methylated
species over the total PGC-1a targets. Nonetheless, we were
cautious as our interpretation was shape primarily around the
PGC-1a[K779me] ChIP-seq data. Moreover, results from the
GO ranking primarily activating genes involved in positive regu-
lation of transcription validated our approach and confirmed
the quality of the dataset. Direct knockdown studies combined
with ChIP analysis revealed some bona fide targets as Pfkl,
Sirt5, Idh3b, and Hmox2 genes. Although a significant pool of
PGC-1a[K779me] resides within the TSS, we were able to
localize a significant binding at enhancer regions that allowed
the characterization of eRNAs overlapping those PGC-1a
[K779me] peaks. Thus, complex ncRNA-protein interactions
appear consequential to the fidelity of transcription and to the
cellular metabolic fate. While the expanded roles of ncRNAs
together with RNA-binding, -processing, and -modifying pro-
teins are emerging as regulators of RNA polymerase II-directed
transcription (Nagaike et al., 2011), none of the published
studies have illustrated a precise mechanism for eRNA function
(Natoli and Andrau, 2012). Here, we provide an unexpected
concept for metabolic regulation by PGC-1a corresponding
with eRNAs under a methylation specific context. Therefore, in
iHep Set7/9 / the expression of these eRNAs was almost
abolished. Furthermore, the binding of PGC-1a[K779me], Medi-
ator and the SAGA component CCDC101/SFG29 at the target
genes was drastically decreased upon Set7/9 knockdown.While
the total PGC-1a pool certainly contains bound RNA the enrich-
ment with PGC-1a[K779me] suggests a regulatory mode for
PGC-1a post-translational modification. The fact that PGC-1a
uses RNA in control of transcription is not unexpected due to
its well-conserved RRM and the previously assumed nature of
PGC-1a tightly coupled with RNA processing (Monsalve et al.,
2000). However, the range of RNA bound by PGC-1a, together
with the role of methylated PGC-1a, provide new insight
regarding the RNA species that may be involved with metabolic
homeostasis.
Our notion that m5C modification of RNA may be coupled
with tRNA, polyadenylated mRNA, and ncRNA stability adds
further complexity to a regulatory mechanism imposed through
eRNA species as an additional class of ncRNAs. Thus, NSun7
depletion corresponded with a loss of m5C on the Pfkl-, Sirt5-,Figure 6. The NSUN7 RNA Methyltransferase Influences PGC-1a Targ
(A) ChIP-qPCR of NSUN7 performed on three discrete regions of the Pfkl and Id
(B) Knockdown of NSun7 results in downregulation of Pfkl, Sirt5, Idh3b, and Hm
(C) qPCR of eRNAs captured by Aza-IP with NSUN7 or IgG control in wild-type
(D) Bisulfite conversion identified specific unconverted N5-methylcytosine in the
through PGC-1a. Hepa1-6 were depleted of Pgc1a and NSun7 by shRNA and
replicates as total RNA were analyzed (n = 2).
CIdh3b-, and Hmox2-associated eRNAs. Furthermore, specific
PGC-1a peaks may suggest that eRNA abundance and turnover
are altered as a result of the depletion of m5C on the measured
transcript. However, themolecular basis of this is not yet evident.
It is plausible to consider that PGC-1a may also respond to
depleted (or elevated) pools of tRNA charged with amino acids
and their correspondingm5C status as ameans to sensitize tran-
scriptional mechanisms of available amino acid pools that can
accommodate or adapt to metabolic states involved with protein
production. This is reminiscent of the simple bacterial model
system exploiting tryptophan attenuation of transcriptional elon-
gation (Babitzke, 2004). Although we have no specific evidence
of such a mechanism for PGC-1a, previous findings indicate
that the majority of substrates for NSUN2, the close homolog
of NSUN7, are tRNAs with a distinct population of polyadeny-
lated mRNAs and ncRNAs (Hussain et al., 2013; Khoddami
and Cairns, 2013). Moreover, new evidence suggests that the
cytosine methyltransferase activity of NSUN5 influences the life-
span in lower eukaryotes by altering rRNA and consequently
ribosome stability (Schosserer et al., 2015). Therefore, like their
tRNA and rRNA counterparts, the status of eRNAs marked
with m5C could be in the direct response to metabolic stress
and provide a greater opportunity to fine-tune responses to
these rapid changes through the transcriptional co-activator
function of PGC-1a. This notion is consistent with our results
showing that overall m5C RNA abundance and NSun7 expres-
sion are altered in liver during fasting in vivo, and that SIRT5
deglutarylase activity on CPS1 is disrupted upon Sirt5 eRNA
depletion.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Supplemental Experi-
mental Procedures. The IACUC approval was granted through protocol
09-0976.
Cell Culture and Inducible Hepatocyte Reprogramming
Cell lines used in this study were obtained from American Type Culture Collec-
tion (ATCC) and cultured according to the supplier’s recommendations. To
induce the differentiation of C2C12 myoblasts, confluent cells were cultured
in low-serum differentiation medium (DMEM, 2% horse serum, and 1 mM insu-
lin), and fresh differentiation medium was changed every 24 hr. For ChIP and
RNA studies,73 107 cells and 23 106 cells were used, respectively. Mouse
embryonic fibroblasts (MEFs) were derived from 13.5-day-old embryos from
wild-type and Set7/9 / mice, corresponding to the C57Bl/6 strain back-
ground (Kurash et al., 2008). Programming of MEFs into induced hepatocytes
was performed essentially as previously described (Sekiya and Suzuki, 2011).
Enhancer-Associated RNA Depletion with LNA-Gapmers
LNAs targeting murine Pfkl and Sirt5 enhancer-associated RNAs or a scram-
bled negative control sequence were designed, synthesized, and supplied
by Exiqon. Detailed LNA sequences used in the eRNA depletion experiments
will be provided upon request.et Gene Expression
h3b loci as shown in the diagram.
ox2 mRNA and the associated eRNAs.
and NSun7 shRNA Hepa1-6 cells.
Pfkl and Sirt5 eRNAs dependent on the presence of NSUN7 and mediated
the total RNA was subjected to bisulfite treatment. Two individual biological
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Figure 7. Physiological Function of Sirt5 eRNA
(A) Northern blot analysis of Sirt5 eRNAs in control and following eRNA depletion with antisense LNA RNAs (LNA-Sirt5) in mouse primary hepatocytes (left). Total
RNA was depicted with ethidium bromide under UV transillumination (right).
(B) Sirt5 eRNA (left) and mRNA (right) qPCR analysis in control and Sirt5 eRNA-depleted Hepa1-6 hepatoma cells and primary mouse hepatocytes.
(C) Western blot of SIRT5 in control and following depletion of the corresponding eRNAs in primary mouse hepatocytes. TUBULIN was used as a loading control
(lower).
(D) Schematics illustrating Tet-On inducible promoter in TRE3G (Clontech) to drive transcription of Evf-2 and Sirt5 eRNAs, respectively (left). Graph showing the
normalized luciferase activity of theSirt5 reporter co-transfected with TRE3G-Evf-2 or TRE3G-Sirt5 eRNA in the presence or absence of doxycycline as indicated.
Endpoint PCR is shown for the Tet On abundance of Sirt5 and Evf-2 eRNAs, respectively.
(E) Immunoblots for total CPS1 (upper) and glutaryl-lysine CPS1 (lower) in control and Sirt5 eRNA-depleted primary mouse hepatocytes.
(F) CPS1 enzyme activity was measure and normalized against the LNA control for luciferase.
(legend continued on next page)
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Enhancer-Associated RNA Reporter Assays
The enhancer RNA for the murine Sirt5 gene was directionally cloned into the
pTRE3G Tet-On inducible system (Clontech) (Table S1) according tomanufac-
turer’s recommendations. The control Evf-2 cDNA was also introduced into
pTRE3G and used as a negative control. ThemurineSirt5 promoter was gener-
ated from mouse Hepa1-6 cell genomic DNA using the primers (forward
50-TCAGGGACAGAGGAGTCACTTCTC; reverse 50-CTCTCAGCACCGTGGC
CCATGG) and cloned into the pBV-LUC backbone acquired from Addgene.
Hepa 1-6 cells were co-transfected with the plasmids described above and
luciferase reporter gene assays were conducted as described previously. In-
duction of eRNA transcription was performed by addiction of tetracycline
into medium according to the manufacturer’s instructions (Clontech).
Quantitation of 5-Methylcytosine (m5C) in RNA
Bisulfite conversion of RNA was analyzed with the EZ RNA Methylation Kit
(Zymo Research) according to the manufacturer’s recommendations.
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